SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

Revolution Medicines is trending following the release of pivotal Phase 3 trial data for its pancreatic cancer candidate, daraxonrasib, which significantly improved overall survival compared to standard chemotherapy. Investors and clinicians are actively discussing the transformative clinical outcomes, which have sparked heightened acquisition speculation and multiple analyst price target increases as the company advances its regulatory filings.

SharonAI Holdings, Inc. operates as a holding company that develops and delivers GPU cloud computing and AI solutions. The company was founded on December 30, 2024 and is headquartered in New York, NY.

SharonAI Holdings Inc. - Ordinary Shares - Class A

SharonAI is currently experiencing intense attention and high volatility driven by a massive multi-year infrastructure contract and strategic positioning from prominent institutional investors like Leopold Aschenbrenner's Situational Awareness. The community is actively debating the stock's potential for a major short squeeze due to its tight float, with many focusing on its role as a niche 'NeoCloud' provider amid broader AI hardware demand.

GSI Technology, Inc. engages in the design, development and marketing of memory products primarily for the networking, and telecommunications markets. Its product includes Static Random Access Memory, or SRAM, which incorporated in networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations and network access equipment. It also offers services to the ongoing needs of the military, industrial, test and measurement equipment, automotive and medical markets for SRAMs .The company was founded by Lee-Lean Shu and Robert Yau in March 1995 and is headquartered in Sunnyvale, CA.

GSI Technology Inc

GSI Technology is trending as investors react to a U.S. Army xTech SBIR contract win for its Gemini-II APU and anticipation regarding its potential role in edge AI and defense sectors. While some community members are bullish on its specialized compute-in-memory architecture, others remain highly skeptical, frequently warning of dilution risks and questioning the competitiveness of their product compared to established industry leaders.

BlackRock, Inc. engages in the provision of investment, advisory, and risk management solutions. Its products include single-asset and multi-asset portfolios. The company was founded by Laurence Douglas Fink and Robert Steven Kapito in 1988 and is headquartered in New York, NY.

Blackrock Inc.

BlackRock is currently trending as the market scrutinizes its private credit division following reports of restricted investor withdrawals and rising loan stress in the sector. Traders are also actively debating the stock's technical position, with many analysts focusing on recent Elliott Wave analysis that identifies a critical support zone as the asset manager faces broader concerns about liquidity and potential systemic risks.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is attracting significant attention as investors anticipate the upcoming FDA decision on the supplemental New Drug Application for Auvelity to treat agitation associated with Alzheimers disease. The community is heavily focused on the drugs clean label potential and the company's aggressive sales force expansion, viewing the pending approval as a transformative catalyst for the firm's commercial growth.

Coeur Mining, Inc. engages in the well-diversified, growing precious metals producer with a focus on generating sustainable, high-quality cash flow and returns from a balanced, prospective asset base in mining-friendly jurisdictions along with commitment to exploration and expansions. It operates through the following segments: Palmarejo, Rochester, Kensington, Wharf and Silvertip. The Palmarejo segment includes a gold-silver complex. The Rochester segment operates an open pit heap leach silver-gold mine in northwestern Nevada. The Kensington segment relates to an underground gold mine located north of Juneau, Alaska. The Wharf segment focuses on an open pit heap leach gold mine located near Lead, South Dakota. The Silvertip segment silver-zinc-lead exploration located in the state of Sonora in northern Mexico. The company was founded in 1928 and is headquartered in Chicago, IL.

Coeur Mining Inc

Coeur Mining is drawing significant community focus due to record-breaking financial performance and the anticipation surrounding its strategic acquisition of New Gold, which is expected to create a diversified gold and copper powerhouse. Investors are actively discussing the firm's strengthened cash flow profile and operational leverage as catalysts for a potential re-rating in a favorable commodities market.

Affirm Holdings, Inc. operates a platform for digital and mobile-first commerce. Its platform consists of three core elements: a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The company was founded by Max R. Levchin in 2012 and is headquartered in San Francisco, CA.

Affirm Holdings Inc - Ordinary Shares - Class A

Affirm Holdings Inc

Affirm is currently trending as a focal point for fintech investors, with strong sentiment driven by its resilient recurring loan revenue and the expansion of its partnership with Google's AI-driven platforms. The community is actively debating the stock's long-term valuation versus cyclical credit risks, with many traders closely monitoring its price action for signs of a major breakout.

Chewy, Inc. operates as an online retailer of pet food and other pet-related products and services. It supplies pet medications, food, treats and other pet-health products and services for dogs, cats, fish, birds, small pets, horses, and reptiles. It has a portfolio of pet healthcare offerings that includes Chewy Pharmacy, Connect with a Vet, and CarePlus, an exclusive suite of pet-first insurance and wellness plans. The company was founded by Ryan Cohen and Michael Day in September 2011 and is headquartered in Plantation, FL.

Chewy Inc - Ordinary Shares - Class A

Chewy Inc

Chewy is currently a focal point for investors as it trades near 52-week lows, fueling intense community debate over whether the stock is a deep-value opportunity or stuck in a long-term downtrend. Market participants are actively discussing the impact of discretionary spending pressures on the company's subscription-based model, with many closely tracking high short interest as a potential catalyst for volatility leading into the next earnings report.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is seeing renewed investor interest and upward price momentum driven by strong institutional backing, consistent GAAP profitability, and a high-volume short interest that has led to speculation about a potential short squeeze. The community is actively discussing the stock's significant undervaluation relative to its growth prospects, while monitoring institutional buying and positive analyst sentiment as key catalysts for a potential breakout.

VanEck ETF Trust - VanEck Gold Miners ETF

VanEck Gold Miners ETF

The VanEck Gold Miners ETF (GDX) remains a focal point for investors as central banks aggressively expand their gold reserves to hedge against geopolitical fragmentation and sustained inflationary pressures. The community is actively debating the sector's long-term outlook, weighing the potential for a monetary reset and fiscal stimulus against short-term volatility driven by rate hike speculation and shifting dollar dynamics.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

GoTu and Henry Schein Announce Strategic Partnership to Strengthen Dental Workforce Support Nationwide

GoTu and Henry Schein Announce Strategic Partnership to Strengthen Dental Workforce Support Nationwide GoTu and Henry Schein Announce Strategic Partnership to Strengthen Dental Workforce Support Nationwide PR Newswire MIAMI, June 30, 2026 MIAMI, June 30, 2026 /PRNewswire/ -- GoTu Technology, the...

Why Henry Schein (HSIC) is a Top Momentum Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

This Henry Schein Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

Wall Street analysts change outlook for top stocks. See upgrades, downgrades, and initiations on analyst ratings page. HSIC stock analysis.read more...

Why Is Henry Schein (HSIC) Up 4.6% Since Last Earnings Report?

Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's Why Henry Schein (HSIC) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Is This the Right Time to Keep HSIC Stock in Your Portfolio?

Henry Schein is backed by a dental and medical distribution scale, digital dentistry push and acquisitions, but debt and macro headwinds weigh on its outlook.

Here's Why Henry Schein (HSIC) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Henry Schein Announces the Election of William K. Dan Daniel as Independent Chairman of the Board

Henry Schein, Inc. (Nasdaq: HSIC), the worlds largest provider of health care solutions to office-based dental and medical practitioners, today announced that its Board of Directors has elected William K. Dan Daniel as Independent Chairman of the Board, effective May 21, 2026. Mr. Daniel succeeds...

Henry Schein Highlights Dental Momentum, $125M Savings Goal Despite Medical Softness

Henry Schein Highlights Dental Momentum, $125M Savings Goal Despite Medical Softness...

MGM Resorts International Now #488 Largest Company, Surpassing Henry Schein

In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, MGM Resorts International (Symbol: MGM) has taken over the #488 spot from Henry Schein Inc (Symbol: HSIC), according to The Online Investor.

 Market capitalization is...

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the following segments: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. The Global Distribution and Value-Added Services segment focuses on distribution to the global dental and medical markets of national brand and corporate brand merchandise, and equipment and related technical services. The Global Specialty Products segment includes manufacturing, marketing and sales of dental implant and biomaterial products, endodontic, orthodontic and orthopedic products. The Global Technology segment focuses on development and distribution of practice management software, e-services, and other products, which are distributed to health care providers. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.

Henry Schein Inc.

KKR To Become 12% Shareholder In Henry Schein With Additional $250M Investment: Retail Cheers The Deal

Equity

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$1.24	--	--	N/A
Q1 '26	$1.22	$1.32	8.38%	BEAT
Q4 '25	$1.30	$1.34	3.02%	BEAT
Q3 '25	$1.28	$1.38	8.04%	BEAT
Q2 '25	$1.19	$1.10	-7.84%	MISSED

Feed

News

Sentiment

Earnings

Fundamentals

Info

HSICHenry Schein Inc.

Upcoming Earnings: Q2 '26

Historical Earnings

Latest HSIC News